Condition: Autism Spectrum Disorders · Sponsor: Hospital General Universitario Gregorio Marañon
study with arbaclofen (4 weeks of titration and then 6 weeks of active/stable treatment). The effects of arbaclofen on target EEG and ERG metrics will be associated with the clinical response in measures of social and general function, adaptive behaviour, social anxiety, sensory behaviours, global functioning, and quality of life in Children and Adolescents with Autism Spectrum Disorders
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Assistance Publique Hopitaux De Paris | Paris, France | Recruiting |
| Hospital Clinic De Barcelona | Barcelona, Spain | Recruiting |
| Hospital General Universitario Gregorio Marañón | Madrid, Spain | Recruiting |
| Hospital Universitario De Salamanca | Salamanca, Spain | Recruiting |
| Complejo Asistencial De Zamora Hospital Provincial De Zamora | Zamora, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07655115